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a b s t r a c t
Speciﬁcation of the trophectoderm (TE) and inner cell mass (ICM) lineages in the mouse blastocyst
correlates with cell position, as TE derives from outer cells whereas ICM from inner cells. Differences in
position are reﬂected by cell polarization and Hippo signaling. Only in outer cells, the apical–basal cell
polarity is established, and Hippo signaling is inhibited in such a manner that LATS1 and 2 (LATS1/2)
kinases are prevented from phosphorylating YAP, a key transcriptional co-activator of the TE-specifying
gene Cdx2. However, the molecular mechanisms that regulate these events are not fully understood.
Here, we showed that inhibition of RHO–ROCK signaling enhances ICM and suppresses TE characteristics
through activation of Hippo signaling and disruption of apical–basal polarity. Embryos treated with
ROCK inhibitor Y-27632 exhibited elevated expression of ICM marker NANOG and reduced expression of
CDX2 at the blastocyst stage. Y-27632-treated embryos failed to accumulate YAP in the nucleus, although
it was rescued by concomitant inhibition of LATS1/2. Segregation between apical and basal polarity
regulators, namely PARD6B, PRKCZ, SCRIB, and LLGL1, was dampened by Y-27632 treatment, whereas
some of the polarization events at the late 8-cell stage such as compaction and apical localization of
p-ERM and tyrosinated tubulin occurred normally. Similar abnormalities of Hippo signaling and apical–
basal polarization were also observed in embryos that were treated with RHO GTPases inhibitor. These
results suggest that RHO–ROCK signaling plays an essential role in regulating Hippo signaling and cell
polarization to enable proper speciﬁcation of the ICM and TE lineages.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The ﬁrst cell differentiation in mammalian development is the
establishment of the two cell lineages, inner cell mass (ICM) and
trophectoderm (TE). ICM is a population of pluripotent stem cells
that give rise to all cell types in the body, whereas TE contributes
only to extraembryonic tissues, namely trophoblasts of the pla-
centa. When the embryo reaches the blastocyst stage, ICM and TE
are distinguishable by their morphology as well as gene expres-
sion patterns (Fujimori, 2010; Marikawa and Alarcon, 2012;
Stephenson et al., 2012; Zernicka-Goetz et al., 2009). TE forms a
monolayer of epithelium surrounding a ﬂuid-ﬁlled cavity, and ICM
forms a single, ovoid-shaped cell aggregate that is situated within
the cavity. TE expresses homeodomain-containing CDX2 and GATA
family member GATA3, whereas ICM expresses POU-domain-
containing POU5F1 and homeodomain-containing NANOG. These
transcription factors play essential roles in maintaining the char-
acteristics of each lineage, as demonstrated by gene knockout and
knockdown studies (Chambers et al., 2003; Home et al., 2009;
Mitsui et al., 2003; Nichols et al., 1998; Strumpf et al., 2005). While
the nature of the initial signals that specify the two cell lineages
during early development is somewhat controversial (Blij et al.,
2012; Hiiragi et al., 2006; Takaoka and Hamada, 2012; Zernicka-
Goetz, 2013), it is evident that the position of cells within an
embryo is critical to direct lineage speciﬁcation toward TE or ICM.
At around 32-cell stage, cells located in the outer layer of the
embryo are committed to differentiating into TE, whereas those
positioned inside are destined to become ICM, as demonstrated by
cell dissociation and cell repositioning experiments (Marikawa
and Alarcon, 2012; Sasaki, 2010; Stephenson et al., 2012; Suwinska
et al., 2008; Zernicka-Goetz et al., 2009). Thus, elucidation of the
molecular mechanisms of how a cell interprets positional informa-
tion to execute lineage-speciﬁc gene expression programs as well
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as to adopt lineage-speciﬁc morphology should help in under-
standing how the mammalian embryo regulates its ﬁrst cell
differentiation event.
Hippo signaling controls organ size through cell proliferation
and apoptosis, and many components of the signaling pathway are
conserved in various animals, ranging from fruitﬂy to mammals
(Johnson and Halder, 2014; Yu and Guan, 2013). Key components
of the Hippo signaling pathway play pivotal roles in cell-lineage
speciﬁcation in the mouse blastocyst. TEA-domain transcription
factor TEAD4 is a downstream effector of Hippo signaling and is
essential for TE formation (Nishioka et al., 2008; Yagi et al., 2007).
While ubiquitously expressed in the embryo, TEAD4 activates Cdx2
expression speciﬁcally in TE, because its transcriptional co-
activator Yes-associated protein (YAP) accumulates in the nucleus
only in the outer cells (Hirate et al., 2012; Nishioka et al., 2009).
YAP is retained in the cytoplasm in inner cells, owing to its
phosphorylation by kinases LATS1 and 2 (LATS1/2) (Hao et al.,
2008). Loss of function of LATS1/2 in mouse embryos leads to
ubiquitous nuclear YAP localization and Cdx2 expression through-
out the embryo, including inner cells, while they form the
blastocyst cavity (Lorthongpanich et al., 2013; Nishioka et al.,
2009). Recent studies have also revealed other regulators of Hippo
signaling that act upstream of LATS, namely AMOT and NF2, and
play critical roles in lineage formation in the mouse blastocyst
(Cockburn et al., 2013; Hirate et al., 2013; Leung and Zernicka-
Goetz, 2013). Thus, differential control of Hippo signaling between
inner and outer cells is a crucial element for the speciﬁcation of
ICM and TE in the mouse blastocyst, i.e., its inhibition induces TE
lineage whereas its activation promotes ICM lineage.
Another key element for linking the positional information (i.e.,
inside versus outside) to lineage speciﬁcation (i.e., ICM versus TE)
is the establishment of apical–basal cell polarity. By the end of
the 8-cell stage, the event known as compaction occurs, in which
the overall appearance of the embryo becomes smooth due to
enhanced cell-cell adhesion. During compaction, all eight cells
start to exhibit polarity along the apical and basal axis. However,
the subsequent cleavages to 16- to 32-cell stages generate inner
and outer cell populations, and only outer cells further establish
distinct apical and basal polarity, while inner cells remain non-
polarized (Eckert and Fleming, 2008; Stephenson et al., 2012).
Various molecules have been identiﬁed that are localized to the
apical or basal membrane in the outer cells, many of which are
homologs of evolutionary conserved cell polarity regulators. For
example, PARD3 (a par-3 homolog), PARD6B (a par-6 homolog)
and PRKCI/PRKCZ (atypical protein kinase C or aPKC) are localized
to the apical membrane, whereas SCRIB (a scribble homolog),
LLGL1 (a lethal giant larva homolog) and MARK2 (a par-1 homo-
log) are conﬁned to the basal membrane (Alarcon, 2010; Dard et
al., 2009; Plusa et al., 2005; Tao et al., 2012; Vinot et al., 2005).
Knockdown of PARD6B causes cavitation failure due to defective
tight junction formation. Also, the expression of CDX2 is dimin-
ished while NANOG expression is elevated in PARD6B-knockdown
embryos, indicating that PARD6B is essential for TE speciﬁcation
(Alarcon, 2010). Furthermore, a recent study has shown that
knockdown of PARD6B impairs nuclear localization of YAP in outer
cells (Hirate et al., 2013), suggesting that the activity of Hippo
signaling is controlled by cell polarity regulators. Thus, delineating
the molecular players that impact Hippo signaling as well as the
apical–basal polarity is the key to understand the mechanisms of
cell-lineage speciﬁcation in the mouse blastocyst.
In the present study, we investigated the role of RHO–ROCK
(Rho-associated kinase) signaling in lineage speciﬁcation, speciﬁ-
cally focusing on its link to Hippo signaling and apical–basal
polarization. ROCK is a serine-threonine kinase and is activated
by its association with RHO small GTPases (Amano et al., 2010;
Amin et al., 2013; Nishioka et al., 2012; Thumkeo et al., 2013).
ROCK phosphorylates a number of protein targets and regulates
various cellular processes, such as cell migration, cytokinesis, and
neurite elongation. It has been shown previously that inhibition of
ROCK during mouse preimplantation development using a speciﬁc
inhibitor, Y-27632, interferes with blastocyst cavity formation
(Kawagishi et al., 2004), raising the possibility that RHO–ROCK
signaling is required for TE lineage formation. Nonetheless, the
impact of RHO–ROCK signaling inhibition on cell-lineage speciﬁ-
cation has not been explored. Moreover, recent studies with
cultured cells showing that inhibition of RHO alters LATS1/2
activity and YAP localization (Mo et al., 2012; Yu et al., 2012;
Zhao et al., 2012) warrant further investigations on the relation-
ship between RHO–ROCK and Hippo signaling in mouse preim-
plantation embryos. Here, we report that inhibition of RHO–ROCK
signaling enhances the ICM lineage and suppresses the TE lineage
formation by impacting Hippo signaling and proper apical–basal
cell polarization.
Materials and methods
Animals and collection of preimplantation embryos and oocytes
F1 (C57BL/6DBA/2) mice from the National Cancer Institute
were used. Female mice were injected with pregnant mare serum
gonadotropin and human chorionic gonadotropin (hCG) (EMD
Millipore) at 48 h apart. For collection of preimplantation
embryos, female mice were mated with males after injection with
hCG, and one-cell (pronuclear) and two-cell stage embryos were
collected from oviducts, using standard protocols (Nagy et al.,
2003). For collection of oocytes, female mice were sacriﬁced about
18 h after hCG injection and oocyte-cumulus cell complex was
recovered from oviducts. Cumulus cells were removed by treat-
ment with 75 U/mL hyaluronidase in FHM HEPES-buffered med-
ium (EMD Millipore), and zona pellucida was digested with
proteases (0.5% Pronase; Roche) in FHM. Oocytes were washed
in FHM several times and carefully examined to conﬁrm no
cumulus cells remained. The protocol for animal handling and
use was reviewed and approved by the University of Hawaii
Institutional Animal Care and Use Committee.
Embryo treatment with pharmacological inhibitors
Stocks of ROCK inhibitor Y-27632 (20 mM, EMD Millipore) and
RHO inhibitor I (100 mg/mL, Cytoskeleton) were dissolved in
dimethyl sulfoxide and water, respectively, and stored at 20 1C
until ready for use. Embryos were treated in 20 mL droplets of
Y-27632 (20 mM) and RHO inhibitor I (1 mg/mL) that were freshly
diluted in KSOM-AA culture medium (MR-121-D, EMD Millipore),
covered with mineral oil, and pre-equilibrated at 37 1C with 5%
CO2 in air. Control treatment was in 20 mL droplets that were
prepared by adding dimethyl sulfoxide or water to KSOM-AA at a
volume equal to that of the inhibitor.
Time-lapse cinematography
Embryo development was recorded in real time, as previously
described (Alarcon, 2010). Brieﬂy, embryos were cultured in a
heated stage of an Axiovert 200 inverted microscope (Carl Zeiss),
which was enclosed in an incubation chamber (PeCon). Tempera-
ture and CO2 concentration were regulated by Tempcontrol 37-2
and CO2-Controller (PeCon). Images were captured every 15
minutes, using AxioCam MRm digital camera, which was con-
trolled by AxioVision software (Carl Zeiss). The incubation cham-
ber was covered with a black plastic sheet during time-lapse
recording.
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Immunoﬂuorescent staining
Procedure was performed, as previously described (Alarcon,
2010). Embryos were incubated in primary antibody at 4 1C and in
secondary antibody at the ambient temperature (22–26 1C).
Primary antibodies were mouse anti-CDX2 (1:200; CDX2-88,
BioGenex), rabbit anti-NANOG (1:800; RCAB0002P-F, Cosmo Bio),
mouse anti-YAP1 (1:100; 2F12, Novus Biologicals), mouse anti-
hemagglutinin (HA) peptide (1:100; 12CA5, Roche), rabbit anti-p-
ERM (1:200; #3141S), rabbit anti-CDH1 (1:500; 24E10) and rabbit
anti-PCM1 (1:500; G2000) from Cell Signaling Technology, rabbit
anti-LLGL1 (1:100; M-102), rabbit anti-PARD6B (1:100; M-64),
mouse anti-PRKCZ (1:100; H-1) and rabbit anti-SCRIB (1:100;
H-300) from Santa Cruz Biotechnology, rabbit anti-TJP1 (1:200;
61-7300, Life Technologies), mouse anti-β-tubulin (1:10,000;
TUB2.1, Sigma-Aldrich), and rat anti-tyrosinated tubulin YL1/2
(1:5000; #ab6160, Abcam). Secondary antibodies were goat anti-
mouse and goat anti-rabbit conjugated with Alexa Fluor 488 (both
at 1:1000; Life Technologies), goat anti-mouse conjugated with
Alexa Fluor 546 (1:1000; Life Technologies), and goat anti-rat
conjugated with rhodamine (1:500; Jackson ImmunoResearch).
F-actin ﬁlaments were visualized by adding phalloidin conjugated
with Alexa 546 (Life Technologies) at a ﬁnal concentration of
33 nM in the secondary antibody solution. Embryos were mounted
in ProLong Gold medium containing 40,6-diamidino-2-phenyl-
indole (DAPI) to visualize nuclei (Life Technologies).
Confocal microscopy and image analysis
Embryos were imaged using FV1000 confocal laser scanning
microscope (Olympus), by capturing serial optical sections at 2 mm
intervals under a 40 oil objective lens. To compare localization
patterns of the target proteins between control and the inhibitor-
treated embryos, we paid speciﬁc attention to the following points
during image capture. Embryos from the same experiment, con-
sisting of control and experimental treatments, were imaged in
a single session using the identical conﬁguration, namely scan
speed, excitation laser power, and detector high voltage (HV)
values. At the beginning of each imaging session, the optimal
value of detector HV for each laser channel was established by
scanning two or three control specimen with varying values using
the saturation-warning function. This was to set the detector HV
value as high as possible without saturating pixels for most
strongly stained areas (e.g., nuclei of outer cells in the case of
CDX2 staining). Z-axis projections of serial optical sections and
examination of every optical section to count nuclei were per-
formed using Fluoview Viewer software (Olympus). To score nuclei
that were positive for CDX2, NANOG, or YAP staining, DAPI
staining was concomitantly visualized to locate the position of
individual nuclei. When CDX2, NANOG, or YAP staining was more
pronounced relative to DAPI staining based on merged colors, it
was scored positive. Speciﬁcally, light blue (green plus dark blue)
or purple (red plus dark blue) nuclei in merged images were
scored positive, whereas dark blue nuclei were scored negative. In
most cases, distinction between positive and negative nuclei was
evident without quantitation. In some experiments, localization of
proteins along the apical–basal cell polarity was assessed using the
ImageJ program (National Institutes of Health). After conversion to
TIFF format, optical sections were opened in ImageJ and pixel
intensities along a straight line across the apical and basal sides of
an outer cell were examined using the Plot Proﬁle Tool.
Reverse transcription-polymerase chain reaction (RT-PCR) analyses
Total RNAwas extracted from each sample of 15–25 embryos or
100–150 oocytes with TRI reagent (Sigma-Aldrich) and used for
cDNA synthesis. Quantitative PCR was performed, using iCycler
Thermal Cycler with MyiQ Single Color Real-Time PCR Detection
System (Bio-Rad), as previously described (Alarcon, 2010). Ampli-
ﬁcation was done with iQ SYBR Green Supermix (Bio-Rad) as
follows: initial denaturation at 94 1C for 5 min, followed by up to
45 cycles of 94 1C for 15 s, 60 1C for 20 s, and 72 1C for 40 s. For
standard RT-PCR to detect Rock1 and Rock2 mRNAs in the oocyte,
ampliﬁcation was performed with JumpStart REDTaq DNA Poly-
merase (Sigma-Aldrich) with the same denaturation, annealing,
and extension conditions as quantitative PCR. Ampliﬁed products
were resolved in 1% agarose gels, and visualized by staining with
ethidium bromide. The following primers were used: Cdx2, F-GAC
TTC CTG TCC CTT CCC TCG TCT, R-CCT CCC GAC TTC CCT TCA CCA
TAC; Gata3, F-CAT GCT CTG TGA ATC AGT CCC TGT, R-AAC CCT CCA
GAG TAC ATC CAC CTT; Nanog, F-ATA ACT TCG GGG AGG ACT TTC
TGC, R-CCC TGA CTT TAA GCC CAG ATG TTG; Pou5f1, F-AGG CAG
GAG CAC GAG TGG AAA GCA, R-GGA GGG CTT CGG GCA CTT CAG
AAA; Sox2, F-CCA TGC AGG TTG ATA TCG TTG GTA, R-GCC AGC CTG
ATT CCA ATA AGA GAG; Tead4, F-CTC AAG GCT TTC TGG TGT CTG
CTT, R-CCT TGT CCC TCA CCT CTG TAG CAT; Actb, F-GAG AGG GAA
ATC GTG CGT GAC ATC, R-CAG CTC AGT AAC AGT CCG CCT AGA;
Rock1-N, F-ATC ATG TCG ACT GGG GAC AGT TTT, R-ATG CAC CTC
TGC CGA TTA CCT TTA (for ampliﬁcation of sequences encoding the
N-terminal end of ROCK1 [262 bp]; spanning the 1st and 2nd
introns); Rock1-M, F-AGG AAA GCA AGA AAG CTG CTT CAA, R-CAT
TCA GCT CCT TCT GGT GTT TCA (for ampliﬁcation of sequences
encoding the middle part of ROCK1 [429 bp]; spanning the 23rd,
24th, and 25th introns); Rock1-C, F-GAT GCC ATG TTA AGT GCC
ACA GAG, R-TTT TTG TGC CAA AAC AAG GAC AGA (for ampliﬁca-
tion of sequences encoding the C-terminal end of ROCK1 [437 bp];
spanning the 31st and 32nd introns); Rock2-N, F-CGG CCG TCA
GAG GAA GCT GGA G, R-CTG AAC TTC ACC AAA AGC ACC TCT (for
ampliﬁcation of sequences encoding the N-terminal end of ROCK2
[250 bp]; spanning the 1st and 2nd introns); Rock2-M, F-GAA CTG
CAA GAC CAA CTT GAA GCA, R-TGC AAG ATT TGC AAC ATC GCT
AGT (for ampliﬁcation of sequences encoding the middle portion
of ROCK2 [378 bp]; spanning the 21st, 22nd, and 23rd introns);
and Rock2-C, F-CAC ATG TTT AAG CCT CCT CCT GCT, R-CGC ACG
TGT GGT GTA TGT ATG TGT (for ampliﬁcation of sequences
encoding the C-terminal end of ROCK2 [443 bp]; spanning the
31st and 32nd introns). Actb was used to normalize gene expres-
sion levels for quantitative PCR. Gene expression analyses were
carried out, using three independent sets of samples.
Synthetic RNA and shRNA plasmid injection
RNA encoding the kinase-dead mutant of LATS2 (LATS2-KD),
phosphorylation-defective mutant YAP with hemagglutinin-
epitope tag (YAP-S112A-HA), and β-globin were synthesized from
cDNAs cloned into the pcDNA3.1-poly(A)83 plasmid (kind gifts of
Drs. Hiroshi Sasaki and Yoshikazu Hirate, Kumamoto University,
Japan). The efﬁcacy of these constructs was previously validated
(Nishioka et al., 2009). Puriﬁed RNAs were injected at the two-cell
stage in both blastomeres, as previously described (Nishioka et al.,
2009). Prevalidated Lats1 and Lats2 short hairpin RNA (shRNA)
plasmids were obtained (TRCN0000022941 for Lats1 and
TRCN0000022705 for Lats2, Sigma-Aldrich). To conﬁrm efﬁcacy
in our hands, P19 mouse embryonal carcinoma cells (American
Type Culture Collection) were transfected with the Lats1 and Lats2
shRNA plasmids and gene expression analysis was conducted, as
previously described (Alarcon, 2010). Enhanced green ﬂuorescent
protein (Egfp) shRNA plasmid (SHC005, Sigma-Aldrich) was used
as control. Puriﬁed shRNA plasmids were injected into one-cell
embryos, as previously described (Alarcon, 2010).
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Statistics
Data were analyzed using Student t-test and chi-square test,
and statistically signiﬁcant differences were deﬁned as po0.05.
Results
Inhibition of ROCK activity impairs TE formation
A previous study has reported that inhibition of ROCK activity
using Y-27632 during preimplantation development interferes
with the formation of the blastocyst cavity (Kawagishi et al.,
2004). To conﬁrm this, we cultured embryos from the 2-cell stage
(E1.5) in the presence of Y-27632 in the culture medium, and
monitored their morphological changes by time-lapse cinemato-
graphy for 3 days (up to E4.5). Timing of the initial cleavages to the
4- and 8-cell stages, and the compaction of blastomeres at the late
8-cell stage were indistinguishable between Y-27632-treated and
non-treated control embryos (Fig. 1A; Supplemental movies).
However, none of the Y-27632-treated embryos (n¼20) formed
a visible blastocyst cavity throughout the entire period of time-
lapse recording, whereas all of the control embryos (n¼20)
generated a robustly expanding cavity. Y-27632-treated embryos
maintained an overall shape of compacted morula with no sign of
cell detachment or dissociation to indicate cell death. The surface
of Y-27632-treated embryos exhibited bulging periodically, which
is indicative of continuous cell divisions. Consistent with this, total
cell numbers were not signiﬁcantly different between Y-27632-
treated and control embryos (Fig. 1B). Thus, ROCK inhibition
impaired blastocyst cavity formation without compromising over-
all cell proliferation.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2014.06.023.
Mutant embryos that are homozygous null for both Rock1 and
Rock2 genes (Rock1/; Rock2 /) die in utero (Kamijo et al.,
2011). However, they appear to form normal blastocysts with an
expanded cavity, which is in striking contrast to the Y-27632-
treated embryos shown in the present study. It is possible that the
mRNA and/or protein products of Rock1 and/or Rock2 are mater-
nally supplied, i.e., stored in the oocyte, which may be sufﬁcient to
support early development of zygotic null (Rock1 /; Rock2/)
embryos up to the blastocyst stage. Thus, we examined whether
Rock1 or Rock2 mRNA was present in unfertilized oocytes by RT-
PCR. To detect mRNA speciﬁcally in the oocyte, ovulated mature
oocytes were treated with proteases to completely remove zona
pellucida along with residual cumulus cells. We also used intron-
spanning primer pairs to conﬁrm that PCR products were
Fig. 1. Inhibition of ROCK activity interferes with blastocyst cavity formation. Embryos were cultured in the absence (control) or presence of Y-27632 from 2-cell to
blastocyst stage (E1.5-E4.5). (A) Development was recorded by time-lapse cinematography. Snap-shot images of control and inhibitor-treated embryos correspond to
developmental stages (from left to right) 8-cell (uncompacted and compacted), morula and early cavitating (E3.5), and late blastocyst with expanded cavity (E4.5). h, hours
post-hCG injection. (B) Comparison of total cell numbers. Circles represent the number of DAPI-stained nuclei in individual embryos, and horizontal dashed bars represent
the mean value for each group. There is no statistically signiﬁcant difference (Student t-test) between control (n¼9) and inhibitor-treated (n¼16) embryos. (C) Presence of
maternal mRNA for Rock1 and Rock2 in the oocyte, as determined by RT-PCR. Lanes 1 and 8 are DNA size marker (100 bp ladder). Lanes 2, 3, and 4 are PCR products of the
Rock1 primers (N, M, and C, respectively). Lanes 5, 6, and 7 are PCR products of the Rock2 primers (N, M, and C, respectively). (D) Disruption of tight junctions by ROCK
inhibition. Representative embryos (E4.5) immunostained for TJP1 (green) are shown. In the control embryo, TJP1 appears as a continuous line in sites of cell-cell contact
between outer cells, whereas in the treated embryo, TJP1 appears discontinuous or absent, and thick rings (arrowheads) of TJP1 are sometimes observed. Images are the
Z-axis projections of optical sections captured by confocal microscopy. Blue, DAPI. Scale bars: (A) 50 mm and (D) 20 mm.
K. Kono et al. / Developmental Biology 394 (2014) 142–155 145
originated from mRNA rather than unprocessed transcripts or
genomic DNA. Three different pairs of primers were used for each
of Rock1 and Rock2 that correspond to regions encoding the
N-terminal, middle, and C-terminal portions of the protein. All
the primer pairs tested ampliﬁed PCR products of predicted size
(Fig. 1C). This result suggests that mRNAs encoding full-length
ROCK1 and ROCK2 are present in the oocyte as maternal supplies.
The formation of the blastocyst cavity requires paracellular
sealing between outer cells, which depends on the establishment
of tight junctions (Eckert and Fleming, 2008; Marikawa and
Alarcon, 2012). To assess whether the failure of cavity formation
in Y-27632-treated embryos is due to defective tight junctions, we
examined the localization of a key component, TJP1 (ZO-1). At the
blastocyst stage, continuous lines of TJP1 staining were observed
along the boundaries between outer cells in control embryos
(n¼9) (Fig. 1D). In contrast, the staining was either discontinuous
or absent in Y-27632-treated embryos (n¼18), suggesting that
defective tight junction formation contributed to the cavitation
failure.
Because tight junction formation is a key feature of TE, we
investigated whether the lineage segregation between TE and ICM
is compromised by ROCK inhibition. The TE and ICM lineages were
assessed by expressions of TE-speciﬁc transcription factor CDX2
and ICM-speciﬁc transcription factor NANOG (Chambers et al.,
2003; Mitsui et al., 2003; Strumpf et al., 2005). The number of
CDX2-positive nuclei was signiﬁcantly lower in Y-27632-treated
embryos compared to the control (Figs. 2A and B). In contrast, the
number of NANOG-positive nuclei was signiﬁcantly increased by
Y-27632 treatment (Figs. 2C and D). Notably, control embryos
expressed NANOG almost exclusively in inner cells, whereas Y-
27632-treated embryos expressed NANOG in both inner and outer
cells (Fig. 2C). Furthermore, quantitative RT-PCR analyses demon-
strated that Y-27632 treatment signiﬁcantly reduced the transcript
levels of Cdx2 and Gata3, but signiﬁcantly increased those of Nanog
and Sox2, another key regulator of ICM pluripotency (Fig. 2E).
These results suggest that the TE lineage is diminished, whereas
the ICM lineage is promoted by ROCK inhibition.
When Y-27632-treated embryos were further cultured beyond
E4.5, some embryos started to form a small cavity whereas the
other embryos partly degenerated with apparently dead cells
being extruded on the surface. It is possible that increased cell
death was due to reduction in CDX2 expression, because Cdx2 null
embryos exhibit increased apoptosis at the blastocyst stage
(Strumpf et al., 2005).
Inhibition of ROCK results in activation of Hippo signaling
Expression of CDX2 in the mouse blastocyst is dependent on
nuclear localization of YAP, which together with TEAD4 acts as a
transcriptional activator (Nishioka et al., 2008, 2009; Yagi et al.,
2007). Because CDX2 expression was reduced in Y-27632-treated
embryos, we examined whether nuclear accumulation of YAP was
also diminished. Between 16- and 32-cell stages, distinct nuclear
YAP was observed in the outer cells of control embryos (Fig. 3A),
whereas fewer nuclear YAP was observed in Y-27632-treated
embryos. The average number of YAP-positive nuclei per embryo
was signiﬁcantly lower (po0.001) in Y-27632-treated embryos
(6.173.7; n¼37) than in control embryos (15.573.3; n¼34),
while the average number of total nuclei per embryo was
comparable between the former (25.575.3) and the latter
(25.775.4) groups (Fig. 3B). This suggests that inhibition of ROCK
diminishes nuclear accumulation of YAP.
In Hippo signaling, nuclear accumulation of YAP is negatively
regulated through its phosphorylation by LATS1/2 (Avruch et al.,
2012; Hao et al., 2008; Hong and Guan, 2012). Phosphorylated YAP
is either sequestered in the cytoplasm by 14-3-3 (Zhao et al., 2007)
or degraded through SCF/β-TrCP E3 ubiquitin ligase (Zhao et al.,
2010). Because nuclear accumulation of YAP was reduced in Y-
27632-treated embryos, it is possible that ROCK inhibition acti-
vated Hippo signaling and promoted LATS1/2 to phosphorylate
YAP. Alternatively, it is possible that ROCK inhibition interfered
with YAP nuclear accumulation through other mechanisms that
are independent from LATS1/2. For example, machineries involved
in nuclear import of YAP may be compromised by Y-27632
treatment. To distinguish between these possibilities, we con-
ducted the following three experiments.
In the ﬁrst experiment, the LATS2 kinase-dead (KD) mutant
was overexpressed in embryos, which were then cultured in the
presence of Y-27632. LATS2-KD acts as a dominant-negative
construct that interferes with YAP phosphorylation by LATS1/2
(Nishioka et al., 2009). Overexpression of LATS2-KD was achieved
by the injection of synthetic mRNA at the 2-cell stage into both
blastomeres. As a control, mRNA encoding β-globin was injected,
followed by Y-27632 treatment. The average number of YAP-
positive nuclei per embryo was signiﬁcantly higher (po0.001) in
LATS2-KD-injected embryos (17.875.9; n¼21) than in β-globin-
injected embryos (6.974.2; n¼31) (Figs. 3A and C). The average
number of total nuclei per embryo was not signiﬁcantly different
between the former (20.875.1) and the latter (24.074.1) groups.
Thus, nuclear accumulation of YAP was rescued in Y-27632-treated
embryos by overexpression of LATS2-KD.
In the second experiment, both Lats1 and Lats2 mRNA were
knocked down by co-injection of speciﬁc shRNA plasmids at the
1-cell stage, and the injected embryos were then treated with
Y-27632 from the 2-cell stage. As a control, shRNA plasmid against
the enhanced Green Fluorescent Protein (Egfp) was injected.
Knockdown of Lats1 and Lats2 rescued YAP nuclear accumulation
in Y-27632-treated embryos, as the average number of YAP-
positive nuclei per embryo was signiﬁcantly higher than in Egfp
shRNA-injected embryos (Figs. 3D and E). This result is consistent
with the ﬁrst experiment, supporting that LATS2-KD speciﬁcally
interfered with the action of LATS1/2 as a dominant-negative
construct.
In the third experiment, we examined the localization of the
YAP-S112A construct in Y-27632-treated embryos. YAP-S112A is a
phosphorylation-defective mutant of YAP, in which the serine
residue for LATS1/2-mediated phosphorylation is replaced with
alanine (Nishioka et al., 2009). We used this construct to test
whether the diminished nuclear localization of YAP by Y-27632
treatment could occur independently from its phosphorylation.
Embryos at the 2-cell stage were injected with mRNA encoding
YAP-S112A tagged with HA epitope, and then cultured in the
absence or presence of Y-27632. The average number of nuclear
YAP-S112A, detected by anti-HA antibody, was not signiﬁcantly
different between control and Y-27632-treated groups (Figs. 3F
and G), indicating that nuclear translocation of YAP-S112A was not
diminished by inhibition of ROCK.
Taken together, these results suggest that ROCK activity is
essential for YAP nuclear accumulation through interference of
its phosphorylation by LATS1/2 in mouse preimplantation
embryos.
Inhibition of ROCK activity causes mislocalization of key components
of the apical–basal cell polarity
Because activity of Hippo signaling is affected by the apical–
basal cell polarity (Genevet and Tapon, 2011; Hirate et al., 2013;
Leung and Zernicka-Goetz, 2013; McCaffrey and Macara, 2011;
Parsons et al., 2010; Thompson et al., 2013; Zhao et al., 2011), we
then investigated the impact of ROCK inhibition on localization of
the key polarity regulators. In control embryos between 16- and 32-
cell stages, the Par-3/Par-6/aPKC complex and the Scribble/Lgl/Dlg
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Fig. 2. Inhibition of ROCK activity promotes ICM and diminishes TE gene expressions. Embryos were cultured in the absence (control) or presence of Y-27632 from 2-cell to
blastocyst stage (E1.5-E4.5). (A) Distribution of the TE lineage marker, CDX2 (red), in representative control and treated embryos (E4.5). (B) Comparison of the number of
CDX2-positive cells. Inhibitor-treated embryos (n¼16) have signiﬁcantly less CDX2-expressing cells (Student t-test) than control embryos (n¼9). Circles represent the
number of CDX2-positive cells in individual embryos, and horizontal dashed bars represent the mean value for each group. (C) Distribution of the pluripotency marker,
NANOG (green), in representative control and treated embryos (E4.5). (D) Comparison of the number of NANOG-positive cells. Inhibitor-treated embryos (n¼10) have
signiﬁcantly more NANOG-expressing cells (Student t-test) than control embryos (n¼7). Circles represent the number of NANOG-positive cells in individual embryos, and
horizontal dashed bars represent the mean value for each group. Images (A and C) are the Z-axis projections of optical sections captured by confocal microscopy. Blue, DAPI.
Scale bars: 20 mm. (E) Quantitative RT-PCR analyses of Y-27632-treated embryos at the early blastocyst stage (100 h post-hCG). Relative expression levels of Tead4, Cdx2,
Gata3, Pou5f1, Nanog, and Sox2 are shown as percentages of their levels in the inhibitor-treated embryos relative to those in control embryos. In each set of experiments, the
expression level of each gene is normalized by that of Actb. Bars indicate mean7standard deviation. P values for Cdx2, Gata3, Nanog, and Sox2 are based on Student t-test,
indicating that the change in these genes by Y-27632 treatment is statistically signiﬁcant.
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complex were distributed in a mutually exclusive manner. Namely,
the components of the former complex, PARD6B (n¼10) and PRKCZ
(n¼14), were preferentially localized to the apical membrane,
whereas those of the latter complex, SCRIB (n¼10) and LLGL1
(n¼11), were localized to the basolateral membranes (Figs. 4A–D),
consistent with the previous observations (Alarcon, 2010; Hirate et
al., 2013; Plusa et al., 2005; Tao et al., 2012; Vinot et al., 2005). In
striking contrast, all of these polarity regulators were mislocalized
in Y-27632-treated embryos. PARD6B (n¼14) and PRKCZ (n¼16)
were no longer restricted to the apical membrane, since they were
also found in the basolateral membrane domain. Similarly, SCRIB
(n¼14) and LLGL1 (n¼16) were distributed along both the apical
and basolateral membrane domains. Thus, the apical and basolateral
components were not segregated from each other in Y-27632-
treated embryos, suggesting that ROCK activity is essential for
proper apical–basal cell polarization.
Because establishment of correct apical–basal cell polarity is
linked to the integrity of cytoskeleton and cell-cell adhesion (Baum
and Georgiou, 2011; McCaffrey and Macara, 2011; St Johnston and
Sanson, 2011), we also compared distributions of actin ﬁlaments,
microtubules, and CDH1 (E-cadherin) between control and Y-
27632-treated embryos at 16- to 32-cell stages (Figs. 4E–G). In both
Fig. 3. ROCK activity is essential for nuclear localization of YAP through interference with its phosphorylation by LATS1/2. (A) Embryos were cultured in the absence or
presence of Y-27632 from 2- to 32-cell stage (E1.5–E3.5). Nuclear YAP (green) diminishes in the outer cells of inhibitor-treated embryos. Overexpression of dominant-
negative LATS (LATS2-KD) rescues nuclear localization of YAP in treated embryos, whereas overexpression of β-globin does not. Cell boundaries are demarcated by F-actin
(red) staining. (B) The numbers of total nuclei and YAP-positive nuclei in untreated (control) and inhibitor-treated embryos. (C) The numbers of total nuclei and YAP-positive
nuclei in inhibitor-treated embryos that have been overexpressed with LATS2-KD and β-globin. (B and C) Circles correspond to individual embryos, which are presented in
the graphs according to the total number of nuclei (x-axis) and the number of YAP-positive nuclei (y-axis). (D) Distribution of nuclear YAP (green) in treated embryos that
have been injected with Egfp shRNA plasmid or a mixture of Lats1-speciﬁc and Lats2-speciﬁc shRNA plasmids. Lats1/Lats2 knockdown rescues nuclear accumulation of YAP.
(E) Comparison of the number of YAP-positive nuclei. Inhibitor-treated embryos injected with Lats1/Lats2 shRNA plasmids (n¼13) have signiﬁcantly more YAP-positive
nuclei (Student t-test) than inhibitor-treated embryos injected with Egfp shRNA plasmid (n¼14). Circles represent the number of YAP-positive nuclei in individual embryos,
and horizontal dashed bars represent the mean value for each group. (F) Distribution of phosphorylation-defective YAP (YAP-S112A) tagged with HA epitope (green) in
untreated and inhibitor-treated embryos. Nuclear localization of YAP-S112A occurs in both treated and control embryos. (G) Comparison of the number of nuclear YAP-S112A.
There is no statistically signiﬁcant difference (Student t-test) between control (n¼10) and inhibitor-treated (n¼10) embryos. Circles represent the number of HA-positive
nuclei in individual embryos, and horizontal dashed bars represent the mean value for each group. Images (A, D, and F) were captured by confocal microscopy. Blue, DAPI.
Scale bars: 20 mm.
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Fig. 4. Localization of polarity proteins in ROCK inhibitor-treated embryos. Embryos were cultured in the absence or presence of Y-27632 from 2- to 32-cell stage (E1.5-E3.5).
(A and B) Immunostaining for PARD6B (green in A) and PRKCZ (green in B) shows strong apical membrane-enrichment in the outer cells of control embryos. With Y-27632
treatment, PARD6B and PRKCZ show membrane-enrichment extending to the basolateral region. (C and D) Immunostaining for SCRIB (green in C) and LLGL1 (green in D)
shows distinct basolateral membrane-enrichment in the outer cells of control embryos. With Y-27632 treatment, SCRIB and LLGL1 showmembrane-enrichment extending to
the apical region. (E and F) Staining for actin ﬁlaments (green in E) and microtubules (green in F) shows no evident difference between control and Y-27632 treatment.
(G) Immunostaining for CDH1 (E-cadherin) shows distinct basolateral membrane-localization in most of the control embryos. With Y-27632 treatment, a signiﬁcantly higher
number of embryos exhibited apical staining of CDH1. Images are optical sections captured by confocal microscopy. Blue, DAPI. Abbreviations: A (apical), B (basal). Scale bar
(A–G): 20 mm.
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groups, actin ﬁlaments were localized along the entire cell mem-
brane, including apical and basolateral sides (n¼18 and 20 for
control and Y-27632-treated, respectively), whereas microtubules
were more diffusely distributed in the cytoplasm, with enrichment
toward the periphery of the embryos (n¼16 and 17 for control and
Y-27632-treated, respectively). Thus, for these cytoskeletal compo-
nents, no clear difference was observed between control and
Y-27632-treated embryos. In contrast, subtle but signiﬁcant altera-
tion in CDH1 distribution was caused by Y-27632 treatment. In
control embryos (n¼16), CDH1 immunostaining was localized
almost exclusively to cell-cell boundaries, and very weak signal
was observed along the apical membranes, although a few embryos
(3 out 16) exhibited distinct apical staining, which was seen as a
discrete peak on the apical end in Plot Proﬁle. However, in Y-27632-
treated embryos (n¼17), many (14 out 17) displayed distinct
staining for CDH1 at the apical membrane (Fig. 4G), and this
frequency was statistically higher than in control embryos
(po0.001; chi-square test). This suggests that ROCK activity is also
essential for conﬁnement of CDH1 to basolateral membranes.
Inhibition of ROCK impairs apical accumulation of PCM1 during
compaction
Molecular signs of apical–basal polarization emerge during
compaction at the late 8-cell stage. Namely, phosphorylated forms
of Ezrin/Radixin/Moesin (p-ERM) are involved in the formation
of apical microvilli, and start to localize at the apical membrane
during compaction (Dard et al., 2004). Also, the asymmetric
reorganization of the microtubule network takes place during
compaction, as tyrosinated tubulin becomes enriched at the apical
cortex, and puncta of pericentriolar material 1 (PCM1) accumulate
near the apical membrane (Houliston and Maro, 1989; Houliston et
al., 1987; Tao et al., 2012). Thus, we investigated whether inhibi-
tion of ROCK activity also affects these early events of apical–basal
polarization.
In compacted 8-cell stage embryos, p-ERM was clearly localized
to the apical cortex in both control (n¼12) and Y-27632-treated
(n¼8) embryos (Fig. 5A). Likewise, apical enrichment of tyrosi-
nated tubulin was indistinguishable between control (n¼7) and
Y-27632-treated (n¼8) embryos (Fig. 5B). In contrast, distribution
patterns of PCM1 were signiﬁcantly different between control and
Y-27632-treated embryos. In control embryos, PCM1 puncta were
accumulated in the area between the apical cortex and nucleus, as
seen in confocal optical sections (Fig. 5C, arrows). Apical accumu-
lation of PCM1 puncta was also evident in Z-projected images as
clusters that were found near the cortex in most (13 out of 17)
embryos (Fig. 5D). However, in Y-27632-treated embryos, apical
accumulation of PCM1 was indistinct in confocal optical sections
(Figs. 5C and D), and a signiﬁcantly less number (2 out of 15) of
embryos exhibited the apical clustering compared to the control
(po0.001; chi-square test). These results suggest that ROCK
inhibition interferes with a certain, but not all, event of apical–
basal polarization at the time of compaction.
Inhibition of RHO activity causes cell polarity and Hippo signaling
defects similar to ROCK inhibition
The activity of ROCK is regulated by RHO GTPases in various
systems (Amano et al., 2010; Ishizaki et al., 1996; Leung et al.,
1996; Matsui et al., 1996). Thus, we examined the role of RHO
GTPases in mouse preimplantation development as a potential
upstream regulator of ROCK to control apical–basal cell polariza-
tion and Hippo signaling. To inhibit the activity of RHO GTPases,
we used RHO Inhibitor I, which is Clostridium botulinum C3
transferase conjugated with a cell-penetrating moiety to pass
through the plasma membrane and inactivate RHOA, RHOB, and
RHOC, but not related GTPases such as CDC42 or RAC1 (Aktories
and Hall, 1989; Han et al., 2001; Just et al., 2001). A previous study
has shown that treatment of mouse embryos with C3 transferase,
starting before the 8-cell stage, interferes with compaction of
blastomeres (Clayton et al., 1999). As shown in the present study,
however, inhibition of ROCK activity from the 2-cell stage did not
impair compaction. Thus, it is possible that RHO GTPases may
regulate compaction in a ROCK-independent manner. Here, to
focus on the role of RHO GTPases as an upstream regulator of
ROCK with respect to cell polarization and Hippo signaling, we
treated embryos with RHO Inhibitor I from the 8-cell stage.
By E3.5, the majority (14 out of 16) of control embryos had
already reached the blastocyst stage, whereas none (0 out of 34) of
RHO inhibitor-treated embryos formed a blastocyst cavity. None-
theless, the average numbers of nuclei per embryo were compar-
able between the control and RHO inhibitor-treated groups
(Fig. 6A), indicating that the lack of cavity formation was not due
to developmental arrest. Also, expression of CDX2 was strikingly
diminished in RHO inhibitor-treated embryos (n¼16) compared to
control embryos (n¼9) (Fig. 6B). Between 16- and 32-cell stages,
the apical marker PARD6B was mislocalized to the basolateral
membrane (n¼10; Fig. 6C), whereas the basolateral marker SCRIB
was mislocalized to the apical membrane (n¼10; Fig. 6D) in RHO
inhibitor-treated embryos. The matching control embryos dis-
played normal localization patterns of these polarity regulators,
i.e., apically enriched PARD6B (n¼5) and basolaterally conﬁned
SCRIB (n¼10). Furthermore, RHO-inhibitor treatment interfered
with nuclear accumulation of YAP, which was reversed by injec-
tion of LATS2-KD mRNA (Figs. 6E and F). Altogether, inhibition of
RHO activity from the 8-cell stage disturbed the localization of
polarity regulators and activated Hippo signaling in a manner
similar to inhibition of ROCK, supporting the notion that RHO–
ROCK signaling plays an essential role in TE formation through
regulation of apical–basal cell polarization and Hippo signaling.
Discussion
A previous study showed that pharmacological inhibition of
ROCK activity during mouse preimplantation development inhi-
bits blastocyst cavity formation (Kawagishi et al., 2004). However,
mechanistic insight into this phenomenon has been absent. For
example, which aspects of the embryonic processes or molecular
events are affected by ROCK inhibition to cause the cavitation
defect has been unknown. In the present study, we showed that
inhibition of RHO–ROCK signaling impaired TE characteristics,
leading to defective tight junction and diminished CDX2 expres-
sion. Nuclear localization of YAP was reduced in RHO–ROCK-
inhibited embryos, likely due to LATS-mediated phosphorylation
of YAP. Indeed, the phenotype of RHO–ROCK inhibition appears
very similar to LATS overexpression with respect to YAP localiza-
tion and CDX2 expression (Nishioka et al., 2009). Inhibition of
RHO–ROCK signaling also disturbed apical–basal cell polarization,
as the key components of the polarity regulators were misloca-
lized. In light of recent studies on Hippo signaling and apical–basal
polarization in TE speciﬁcation (Alarcon, 2010; Cockburn et al.,
2013; Hirate et al., 2013; Leung and Zernicka-Goetz, 2013;
Lorthongpanich et al., 2013; Nishioka et al., 2009), we propose
that RHO–ROCK signaling is a key element of proper lineage
formation in preimplantation development by inﬂuencing Hippo
signaling and cell polarization.
Y-27632-treated embryos exhibited severe defects in cavitation
and TE speciﬁcation, whereas Rock1 and Rock2 zygotic null
(Rock1 /; Rock2/) embryos appear to form normal blastocysts
with an expanded cavity (Kamijo et al., 2011). A possible reason for
such phenotypic difference is that the products of Rock1 and/or
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Rock2 genes are maternally supplied, as shown in the present study,
which may be sufﬁcient to support early preimplantation develop-
ment in zygotic mutants. However, at this point, we cannot
completely rule out the possibility that Y-27632 may interfere with
unknown targets other than ROCK, which led to the cavitation
failure observed in this study and previously (Kawagishi et al., 2004).
Nonetheless, we showed that RHO inhibitor I also produced essen-
tially the same sets of abnormalities, i.e., cavitation failure, reduced
CDX2 expression, LATS-mediated inhibition of YAP nuclear localiza-
tion, and mislocalization of polarity regulators, which strongly
suggests that inhibition of RHO–ROCK signaling was responsible
for the observed phenotype. Interestingly, some of these abnormal-
ities, speciﬁcally reduction in CDX2 expression and YAP nuclear
localization, appeared to be more pronounced in RHO-inhibited than
in ROCK-inhibited embryos (compare Fig. 6 with Figs. 2 and 3). It is
possible that RHO inhibitor I is more efﬁcient in blocking RHO–ROCK
signaling than Y-27632. Alternatively, RHO GTPases may play an
additional role in the regulation of Hippo signaling in a ROCK-
independent manner, and thus inhibition of RHO GTPases may exert
stronger impact than inhibition of ROCK alone.
Studies using cultured cells have shown that RHO GTPases
modulate YAP activity in response to various mechanical and
biochemical microenvironments, such as cell attachment to sub-
strate, stiffness of substrate, activation of protease-activated recep-
tors, and ligands to G protein-coupled receptors (GPCR), including
serum lipid components (sphingosine-1-phosphate [S1P] and lyso-
phosphatidic acid) and hormones, namely epinephrine and gluca-
gon, that up-regulate intracellular cAMP level (Dupont et al., 2011;
Miller et al., 2012; Mo et al., 2012; Yu et al., 2012, 2013; Zhao et al.,
2012). Even though the nature of the microenvironments is diverse,
RHO GTPases play an essential role in the activation of YAP in all of
these cases, which is in line with the situation in preimplantation
embryos, as shown in the present study. However, mechanisms that
connect RHO GTPases to YAP appear to differ signiﬁcantly among
these cases, particularly with respect to the involvement of ROCK.
ROCK acts downstream of RHO GTPases and is required for activa-
tion of YAP in the sensing of substrate stiffness (Dupont et al., 2011)
and response to S1P (Miller et al., 2012). In contrast, ROCK activity
appears to be dispensable in response to protease-activated recep-
tor signaling (Mo et al., 2012) or cell attachment to substrate (Zhao
et al., 2012), in which treatment with a pharmacological ROCK
inhibitor does not impair YAP activation. Furthermore, involvement
of LATS in YAP phosphorylation appears to be different among these
cases. Speciﬁcally, responses to S1P and activation of protease-
activated receptors involve LATS (Mo et al., 2012; Yu et al., 2012),
whereas sensation of stiffness does not (Dupont et al., 2011). Thus,
there is more than one pathway that connects RHO GTPases to YAP
activation depending on the biological events and possibly on cell
types. This may possibly be the case in mouse preimplantation
development, which might have contributed to apparently stronger
impact of RHO inhibitor I than Y-27632, as discussed above.
Recently, we have shown that inhibition of ROCK activity with
Y-27632 at later stages of preimplantation development, speciﬁ-
cally between E3.5 and E4.5 during cavity expansion, alters ICM
morphology without compromising speciﬁcation of TE, epiblast,
and primitive endoderm lineages. These embryos that are treated
with Y-27632 at later stages are still capable of implantation,
but are impaired in post-implantation development, resulting in
Fig. 5. ROCK inhibition does not interfere with all events of cell polarization at the time of compaction of the 8-cell stage embryo. Embryos were cultured in the absence or
presence of Y-27632 from 2- to 8-cell (compacted) stage (E1.5-E2.5). (A and B) Immunostaining for p-ERM (green in A) and tyrosinated tubulin (red in B) shows retention of
strong localization in the apical domain in inhibitor-treated embryos that is similar to that in control embryos. (C) Immunostaining for PCM1 (green) shows puncta (arrows)
clustered between the apical domain and nucleus in the control embryo. With ROCK inhibition, the apical clustering is lost. Cell boundaries are demarcated by staining for
F-actin (red). Images (A–C) are optical sections captured by confocal microscopy. (D) Projections of optical sections in the Z-axis of the embryo immunostained for PCM1
(green). Blue, DAPI. Scale bars: 10 mm.
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Fig. 6. RHO inhibition phenocopies the Y-27632-induced disruption of cell polarity and activation of Hippo signaling in embryos. Embryos were cultured in the absence or
presence of RHO Inhibitor I from 8- to 32-cell stage (E2.5–E3.5). (A) Comparison of total nuclear numbers. There is no statistically signiﬁcant difference (Student t-test)
between control (n¼16) and inhibitor-treated (n¼35) embryos. Circles represent the number of DAPI-stained nuclei in individual embryos, and horizontal dashed bars
represent the mean value for each group. (B) Immunostaining for the TE lineage marker, CDX2 (red), in representative embryos. CDX2 is diminished in the inhibitor-treated
embryo. Images are Z-axis projections of optical sections. (C and D) Immunostaining for apical–basal polarity proteins in representative embryos. In the control embryo,
PARD6B (green in C) is strongly enriched in the apical domains and weakly enriched in the basolateral domains of outer cells. With inhibitor treatment, PARD6B localization
becomes more distinct in the basolateral region. On the other hand, SCRIB (green in D) is enriched in the basolateral domains of outer cells in the control embryo, but also
becomes localized in the apical domains in the treated embryo. Images are optical sections. Abbreviations: A (apical) and B (basal). (E) Nuclear YAP (green) diminishes in the
inhibitor-treated embryo. Overexpression of dominant-negative LATS (LATS2-KD) rescues nuclear localization of YAP in the inhibitor-treated embryo. Images are the Z-axis
projections of optical sections. (F) Comparison of the number of YAP-positive nuclei. Nuclear localization of YAP is signiﬁcantly reduced in RHO inhibitor-treated embryos
(n¼18) compared to untreated control embryos (n¼11; Student t-test). Nuclear localization of YAP is restored in inhibitor-treated embryos that have been overexpressed
with LATS2-KD (n¼12; Student t-test). Circles represent the number of YAP-positive nuclei in individual embryos, and horizontal dashed bars represent the mean value for
each group. Blue, DAPI. Scale bars: 20 mm.
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signiﬁcantly higher incidence of fetal loss (Laeno et al., 2013).
Thus, the impact of Y-27632-treatment at later stages of preim-
plantation development is more in line with the post-implantation
lethality phenotype of Rock1 /; Rock2/ embryos (Kamijo et al.,
2011), although further investigations are required to determine
when and how exactly these embryos die in utero. Also, future
studies to generate compound knockout embryos, in which both
maternal and zygotic Rock1 and Rock2 are completely removed,
should clarify the role of ROCK in early stages of preimplantation
development.
Previously, we have demonstrated that knockdown of PARD6B
impairs TE lineage formation while enhancing ICM characteristics
(Alarcon, 2010). PARD6B-knockdown embryos and RHO–ROCK-
inhibited embryos share many phenotypic similarities, such as
cavitation failure, defective TJP1 distribution, diminished Cdx2
expression, elevated Nanog expression, reduced YAP nuclear locali-
zation, and mislocalization of SCRIB and LLGL1 to the apical domain
(Alarcon, 2010; Hirate et al., 2013). These similarities implicate a
mechanistic link between RHO–ROCK signaling and PARD6B, or
more broadly the Par-3/Par-6/aPKC complex. Indeed, studies using
cultured cell lines have shown that these two systems can mutually
regulate each other through protein phosphorylation. Speciﬁcally,
ROCK phosphorylates PAR3 to regulate its association with the
complex (Nakayama et al., 2008), whereas aPKC phosphorylates
ROCK in a Par-3/Par-6-dependent manner to modulate the integrity
of apical junctional complexes (Ishiuchi and Takeichi, 2011). How-
ever, there are also noteworthy differences between PARD6B-
knockdown and RHO–ROCK-inhibited embryos. First, PARD6B is
largely absent in the PARD6B-knockdown embryos, whereas it is
still present and distributed to both the apical and basal domains in
RHO–ROCK-inhibited embryos. Second, PRKCZ (aPKCzeta) is dif-
fused into the cytoplasm in the former embryos, whereas it is
localized to the entire cortex in the latter (Alarcon, 2010). Also, the
apical localization of p-ERM is reduced in PARD6B-knockdown
embryos (Hirate et al., 2013), whereas it was intact in RHO–ROCK-
inhibited embryos. Thus, relationships between RHO–ROCK signal-
ing and PARD6B may be more complex than simple mutual
regulation. Nonetheless, RHO–ROCK-inhibited embryos present a
unique situation with respect to localization of polarity regulators,
which may be useful for further investigations of the mechanisms of
apical–basal cell polarization. Speciﬁcally, in RHO–ROCK-inhibited
embryos, components of the apical (Par-3/Par-6/aPKC) complex and
the basal (Scribble/Lgl/Dlg) complex co-existed in the same cortical
domains. In many epithelial cell types, distinct apical and basal
domains are clearly separated by mutually antagonistic regulations
between polarity regulators. For example, the apical component
aPKC can phosphorylate basal components PAR1 and LGL to prevent
their association with the apical membrane (Hurov et al., 2004;
Suzuki et al., 2004; Yamanaka et al., 2003), whereas PAR1 can
phosphorylate PAR3 to interfere with its interaction with aPKC
(Benton and St. Johnston, 2003). It is of particular interest in future
studies to examine how the mutual antagonistic mechanisms are
affected in RHO–ROCK-inhibited embryos.
The present study as well as the previous studies (Alarcon, 2010;
Hirate et al., 2013; Leung and Zernicka-Goetz, 2013) suggest that
Hippo signaling is under the control of apical–basal cell polarity in
mouse preimplantation embryos. Formation of intact apical–basal
polarity inactivates Hippo signaling, which results in YAP nuclear
accumulation to turn on TEAD4-mediated transcriptional regulation.
If TEAD4 is to be required for epithelialization of TE, as implicated
previously (Alarcon, 2010; Nishioka et al., 2008; Yagi et al., 2007),
dependence of blastocyst cavitation on the apical–basal cell polarity
may be mediated by Hippo signaling. Alternatively, the apical–basal
cell polarity may play more direct roles in TE epithelialization
independently from Hippo signaling, as the polarity regulators have
been shown to control the formation and integrity of epithelial
architectures in various systems (Chen and Zhang, 2013; McCaffrey
and Macara, 2011). Interestingly, a recent study has shown that Tead4
null zygotes can form a blastocyst cavity when cultured under
hypoxic condition (5% oxygen; Kaneko and DePamphilis, 2013). In
further studies, it is of particular interest to investigate whether RHO–
ROCK-inhibited or PARD6B-knockdown embryos can form a blasto-
cyst cavity under hypoxic condition, which may shed light on how TE
epithelialization is regulated by the apical–basal cell polarity and
Hippo signaling.
Even though many apical–basal components were mislocalized in
ROCK-inhibited embryos, not all polarization events were interfered
with, particularly around the time of compaction at the late 8-cell
stage. Apical accumulation of PCM1 puncta was inhibited by Y-27632
treatment, whereas apical localizations of p-ERM and tyrosinated
tubulin were unaffected. The role of apical PCM1 is currently
unknown, although injection of function-interfering anti-PCM1 anti-
body into fertilized eggs blocks cell cycle progression (Balczon et al.,
2002). Interestingly, physical association between PCM1 and PARD6A
at the centrosomes and centriolar satellites has been observed in cell
lines (Kodani et al., 2010). This raises the possibility that accumula-
tion of PCM1 may be involved in guiding the Par-3/Par-6/aPKC
complex to the apical cortex.
Our study implicates that RHO GTPases act through ROCK to
activate YAP in a LATS-mediated manner in preimplantation
embryos. Nonetheless, it is also possible that the impact of RHO–
ROCK signaling on YAP is an indirect consequence of disturbed
apical–basal cell polarization, as discussed above. Further investi-
gations on more detailed mechanisms linking RHO–ROCK to YAP
in preimplantation embryos should help distinguish between
these possibilities.
While this manuscript was under review, a new study was
published, reporting that treatment of mouse preimplantation
embryos with Y-27632 causes defects in the ﬁrst cleavage and
failure in compaction at the 8-cell stage (Duan et al., 2014). These
adverse effects of Y-27632 appear more severe than those shown
in the present study, and further investigations are required to
resolve such apparent discrepancy. Nonetheless, it is important to
point out several differences in experimental procedures. In the
study by Duan et al. (2014), a much higher concentration of
Y-27632 (100 μM) is used compared to the present study
(20 μM). Also, the embryo culture condition in Duan et al. (2014)
appears to be suboptimal because only about 50% of embryos have
reached the morula/blastocyst stage in some experiments. This is
in striking contrast to the condition in the present study, which
supported development of nearly 100% of embryos to expanded
blastocysts. It is possible that the use of a very high concentration
of the inhibitor in conjunction with suboptimal culture condition
may have contributed to the more severe developmental defects in
Duan et al. (2014).
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